Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging
Year: 2021
Type: article
Abstract: Immunotherapies are revolutionizing cancer treatment by boosting the natural ability of the immune system. In addition to antibodies against traditional checkpoint molecules or their ligands (i.e., CTLA-4, PD-1, and PD-L1), therapies targeting molecules such as ICOS, IDO-1, LAG-3, OX40, TIM-3, and VISTA are currently in clinical trials. To better inform clinical care and the design of therapeutic combination strategies, the co-expression of immunoregulatory proteins on individual immune cells within the tumor microenvironment must be robustly characterized. Highly multiplexed tissue imaging platforms, such as CO-Detection by indEXing (CODEX), are primed to meet this need by enabling >50 markers to be simultaneously analyzed in single-cells on formalin-fixed paraffin-embedded (FFPE) tissue sections. Assembly and validation of antibody panels is particularly challenging, with respect to the specificity of antigen detection and robustness of signal over background. Herein, we report the design, development, optimization, and application of a 56-marker CODEX antibody panel to eight cutaneous T cell lymphoma (CTCL) patient samples. This panel is comprised of structural, tumor, and immune cell markers, including eight immunoregulatory proteins that are approved or currently undergoing clinical trials as immunotherapy targets. Here we provide a resource to enable extensive high-dimensional, spatially resolved characterization of the tissue microenvironment across tumor types and imaging modalities. This framework provides researchers with a readily applicable blueprint to study tumor immunology, tissue architecture, and enable mechanistic insights into immunotherapeutic targets.
Source: Frontiers in Immunology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,623
Funders: National Science Foundation, Bill and Melinda Gates Foundation, Cancer Research Institute, Lady Tata Memorial Trust, Parker Institute for Cancer Immunotherapy, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, National Institutes of Health, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Stanford Cancer Institute
Awards: Highly multiplexed ion-beam tissue molecular imaging with sub-micron resolution, Systems Approach to Immunity and Inflammation, Exploiting the Host-HIV Interface To Identify Biomarkers Predicting Time to Viral Rebound after Treatment Interruption, T Cell Reagent Research for Monitoring T Cell in Food Allergy, Omics for TB: Response to Infection and Treatment, Identifying Survivors of HSP90 Inhibitor Treatment In Breast Cancer by Mass Cytometry, G3705789948, Stanford Tissue Mapping Center, The Cellular Geography of Therapeutic Resistance in Cancer, Tissue Cytokine Sequestration and Immune Regulation in Autoimmunity, Integrating mass cytometric and transcriptomic profiles of solid tumors, Hyper-parameter 3D imaging of the bone marrow hematopoietic stem cell niche in leukemia and stress hematopoiesis by co-detection of expression (CODEX), Applicability of Mouse Breast Cancer Models to Tumor-Immune Network Investigation, Stanford Technology Accelerating Medicines Partnership Center, Multiscale Modeling of Myelodysplastic Syndromes, Modeling the Role of Lymph Node Metastases in Tumor-Mediated Immunosuppression, G73616645, Balanced signaling cues to guide cell transitions in the blood lineage continuum, Multidimensional cellular interrogation of the kidney in AKI and CKD, Characterizing the immune and metabolic profiles of cutaneous T-cell lymphoma in formalin-fixed paraffin-embedded skin tissue samples, Deep phenotyping of the tumor microenvironment in hematological cancers by CODEX hyper-parameter tissue imaging, Oregon Health & Science University - to discover circulating markers to determine the size of the HIV reservoir in the body, to clinically test interventions that might reduce the size..., The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy, Elafin Therapy for Pulmonary Arterial Hypertension, Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro, Postgraduate Training in Epithelial Biology
OpenAlex ID: W3162853653
